Diabetes
Report Summarizes Diabetes Study Findings from Radboud University
Published in Obesity and Diabetes Week, October 17th, 2011
2011 OCT 17 -- In this recent report, researchers in Nijmegen, Netherlands conducted a study "To study the overall effect of the Active Prevention in High-Risk Individuals of Diabetes Type 2 in and Around Eindhoven (APHRODITE) lifestyle intervention on type 2 diabetes risk reduction in Dutch primary care after 0.5 and 1.5 years and to evaluate the variability between general practices. Individuals at high risk for type 2 diabetes (Finnish Diabetes Risk Score 3) were randomly assigned into an intervention group (n = 479) or a usual-care group (n = 446)."
"Comparisons were made between study groups and between general practices regarding changes in clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity
Studies from R. Li et al Further Understanding of Obesity - Obesity
A hormone that fights fat with fat - Diabetes
Data on Diabetes Discussed by Researchers at Centocor - Diabetes
Findings in Diabetes Reported from University of Ottawa - Gladstone Institutes
Gladstone experiments suggest research avenues for treating excess fat storage and obesity - Diabetes
Investigators at University of Wisconsin Target Diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
